SCHEMBL19426331

SCHEMBL19426331

N=C(N)NCCCC(NC(=O)CN)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NCC(=O)O

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 3/20 0.40
ITGA2B P08514 2/20 0.40
PTGS1 P23219 1/20 0.37
GSTK1 Q9Y2Q3 1/20 0.37
QRFPR Q96P65 1/20 0.36
NPY4R P50391 6/20 0.36
NPY5R Q15761 6/20 0.36
NPY1R P25929 5/20 0.36
NPY2R P49146 3/20 0.36
GLO1 Q04760 1/20 0.35
KEAP1 Q14145 2/20 0.35
MDM4 O15151 1/20 0.34
ITGB1 P05556 1/20 0.34
ITGAV P06756 1/20 0.34
ITGA5 P08648 1/20 0.34
TFPI P10646 1/20 0.34
IL23R Q5VWK5 1/20 0.34
OPRL1 P41146 1/20 0.33
PTGER4 P35408 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19426417 1.00 ITGB3 (0.40) ITGB3ITGA2BPTGS1GSTK1QRFPR
SCHEMBL21961850 1.00 ITGB3 (0.40) ITGB3ITGA2BPTGS1GSTK1QRFPR
SCHEMBL29630767 0.95 NPY4R (0.39) ITGB3ITGA2BPTGS1GSTK1QRFPR
SCHEMBL12015094 0.93 QRFPR (0.40) ITGB3ITGA2BQRFPRNPY4RNPY5R
SCHEMBL12646501 0.93 ITGB3 (0.38) ITGB3ITGA2BPTGS1GSTK1QRFPR
SCHEMBL29405094 0.93 ITGB3 (0.38) ITGB3ITGA2BPTGS1GSTK1QRFPR
SCHEMBL29591850 0.93 QRFPR (0.39) ITGB3ITGA2BPTGS1GSTK1QRFPR
SCHEMBL29354257 0.93 PTGS1 (0.41) PTGS1GSTK1QRFPRNPY4RNPY5R
SCHEMBL29590376 0.92 QRFPR (0.42) PTGS1GSTK1QRFPRNPY4RNPY5R
SCHEMBL29630453 0.92 PTGS1 (0.39) PTGS1GSTK1QRFPRNPY4RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017172930-A1 PBD CONJUGATES FOR TREATING DISEASES ENDOCYTE, INC. (US) 2017-10-05 WO disclosed